We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioMed X Starts New Schizophrenia Research Program with Boehringer Ingelheim

Product News   Jan 15, 2020

 
BioMed X Starts New Schizophrenia Research Program with Boehringer Ingelheim
FURTHER INFORMATION
 
 
 

Related Product News

Selonterra To Present Alzheimer’s Disease Therapy Program at Biotech Showcase™ 2020

Product News

Selonterra, a biotechnology company with the aim of discovering therapies for neurodegenerative disorders by harnessing human genetics and gene regulatory networks, has announced a presentation at the Biotech Showcase™ 2020.

READ MORE

Drug Therapy for Demyelinating and Neuroinflammatory Diseases Given US Patent

Product News

MetP Pharma has announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for its patent entitled “Treatment of Demyelinating Diseases”.

READ MORE

New Biomarker of Parkinson’s Disease Progression

Product News

SynapCell and Motac Neuroscience have discovered a new biomarker for monitoring the progression of Parkinson’s disease.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE